Drugs for Late-Onset Retinal Degeneration (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 156)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
|
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
|
Sodium citrate, anhydrous
Sodium citrate,anhydrous
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
2 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311
|
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-carboxy-3-hydroxypentane-1,5-dioic acid
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
|
Citretten
Citric acid monoglyceride
Citric acid monohydrate
Citric acid, anhydrous
Citric Acid, Anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
H3Cit
Hydrocerol a
Kyselina citronova
Monohydrate, citric acid
Suby g
Uralyt u
uro-Trainer
|
|
3 |
|
Sildenafil Citrate |
|
Phase 4 |
|
171599-83-0 |
|
4 |
|
Citrate |
|
Phase 4 |
|
|
|
5 |
|
Antibodies |
|
Phase 4 |
|
|
|
6 |
|
Immunoglobulins |
|
Phase 4 |
|
|
|
7 |
|
Autoantibodies |
|
Phase 4 |
|
|
|
8 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
9 |
|
Phosphodiesterase 5 Inhibitors |
|
Phase 4 |
|
|
|
10 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
11 |
|
Vardenafil Dihydrochloride |
|
Phase 4 |
|
|
|
12 |
|
Hormones |
|
Phase 4 |
|
|
|
13 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
14 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 4 |
|
|
|
15 |
|
Adrenocorticotropic Hormone |
|
Phase 4 |
|
|
|
16 |
|
beta-endorphin |
|
Phase 4 |
|
|
|
17 |
|
Melanocyte-Stimulating Hormones |
|
Phase 4 |
|
|
|
18 |
|
Tocopherol |
Approved, Investigational |
Phase 3 |
|
1406-66-2, 54-28-4 |
14986
|
Synonyms:
3,4-dihydro-2,7,8-Trimethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol
7,8-Dimethyltocol
7,8-dimethyltocolo-Xylotocopherol
Abortosan
adisseo Brand OF tocopherol
Alcala brand OF tocopherol acetate
Aliud brand OF tocopherol
Antioxidans e-hevert
Aquasol e
Arkopharma brand OF tocopherol acetate
AstraZeneca brand OF tocopherol acetate
Atarost brand OF tocopherol acetate
Ausrichter brand OF tocopherol
Auxina e
Balkanpharma brand OF tocopherol
Bayer brand OF tocopherol acetate
bio e
Biocur brand OF tocopherol acetate
biopto-e
Biosan
Bioweyxin
Blackmores brand OF tocopherol
Bottger brand OF tocopherol acetate
Cambridge laboratories brand OF tocopherol actetate
Dal e
Dal vita brand OF vitamin e succinate
Dal-e
Dal-vita brand OF vitamin e succinate
Davitamon
Dermorelle
Detulin
D-gamma-Tocopherol
DL-alpha-Tocopherol
DL-a-Tocopherol
DL-α-tocopherol
Dragees, vitamin-e
e Ferol
e Mulsin
e Vicotrat
e Vitamin e
Ecoro
e-Ferol
Elex verla
Embial
e-Mulsin
Ephynal
Eplonat
Equivit e
Eu rho brand OF tocopherol
EUNOVA vitamin e
Eusovit
e-Vicotrat
EVI-mirale, vitamin-e
Evion
e-Vitamin-ratiopharm
GNR Pharma brand OF tocopherol actetate
GNR-Pharma brand OF tocopherol actetate
Grace brand OF tocopherol
Grunwalder brand OF tocopherol
g-Tocopherol
Hervert brand OF tocopherol acetate
Heyl brand OF tocopherol acetate
Hydrovit e
ICN brand OF tocopherol acetate
Infirmarius rovit brand OF tocopherol
Infirmarius-rovit brand OF tocopherol
Internation animal health brand OF tocopherol acetate
Jenapharm brand OF tocopherol
Kentucky brand OF tocopherol
Kohler brand OF tocopherol
Lasar
Malton e
medphano Brand OF tocopherol acetate
Merck brand OF tocopherol acetate
Methyltocols
Micorvit e
MIP brand OF tocopherol acetate
Mowivit vitamin e
Mucos brand OF tocopherol acetate
Organon brand OF tocopherol acetate
O-Xylotocopherol
puncto e
Ratiopharm brand OF tocopherol
Richelet brand OF tocopherol acetate
|
Richtavit e
Riemser brand OF tocopherol
Roche nicholas brand OF tocopherol acetate
Rodisma med brand OF tocopherol
Rodisma-med brand OF tocopherol
Sanavitan S
Sanum kehlbeck brand OF tocopherol actetate
Sanum-kehlbeck brand OF tocopherol actetate
Schwarzhaupt brand OF tocopherol acetate
Sciencex brand OF tocopherol acetate
Scot tussin brand OF tocopherol acetate
Scot-tussin brand OF tocopherol acetate
Snow-e muscle, energy and feritility
Spondyvit
Stadapharm brand OF tocopherol
Steigerwald brand OF tocopherol acetate
Strathmann brand OF tocopherol
tocoferol
tocoferoles
Tocolion
Tocopa
Tocopharm
Tocopherol
tocophérol
Tocopherol ausrichter brand
Tocopherol balkanpharma brand
Tocopherol bayer
Tocopherol grace brand
Tocopherol grunwalder brand
Tocopherol infirmarius-rovit brand
Tocopherol kentucky brand
Tocopherol ratiopharm brand
Tocopherol rodisma-med brand
Tocopherol stadapharm brand
Tocopherol togal brand
Tocopherol twardy brand
Tocopherol verla brand
Tocopherol wiedemann brand
Tocopherol worwag brand
Tocopherols
Tocovital
Togal brand OF tocopherol
Togasan vitamin e
Troyapharm brand OF tocopherol acetate
Twardy brand OF tocopherol
Unique e
uno Vit
uno-Vit
UnoVit
Verla brand OF tocopherol
Veyx brand OF tocopherol
Vibolex
Vit e hydrosol
Vit. e stada
Vita e
Vita plus e
Vita-e
VitaE
Vitagutt vitamin e
Vitamin e al
Vitamin e dragees
Vitamin e evi mirale
Vitamin e gamma
Vitamin e MP
Vitamin e natur
Vitamin e sanum
Vitamin e suspension
Vitamin e, mowivit
Vitamin e, togasan
Vitamin e, vitagutt
Vitamin emp
Vitamin e-MP
Vitamin-e dragees
Vitamine e GNR
Vitamin-e evi-mirale
Vita-plus e
VitaPlus e
Vitazell
Wiedemann brand OF tocopherol
Wiedemann brand OF vitamin e succinate
Woelm brand OF tocopherol acetate
Worwag brand OF tocopherol
γ-tocopherol
|
|
19 |
|
Vitamin A |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
22737-96-8, 11103-57-4, 68-26-8 |
9904001
445354
|
Synonyms:
(11-cis,13-cis)-Retinol acetate
(13cis)-Retinol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
[11,12-3H]-Retinol
11,13-Di-cis-vitamin a acetate
11103-57-4
11-cis-13-cis-Retinol acetate
11-cis-13-cis-Retinyl acetate
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
alin
All Trans Retinol
All-trans retinol
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-retinol
all-trans-Retinol
all-trans-retinyl alcohol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-vitamin A alcohol
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
Alphalin
Alphasterol
A-Mulsal
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
AR-1L3057
A-Sol
Atars
ATAV
Avibon
A-Vi-Pel
Avita
A-Vitan
Avitol
Axerol
Axerophthol
Axerophtholum
Bentavit A
beta-Retinol
BIDD:PXR0102
Biosterol
BRN 0403040
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
Chocola A
CID445354
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
Hi-A-Vita
|
HMS1921B04
HMS2092L13
HMS501I08
Homagenets Aoral
Homagenets aorl
HSDB 815
Hydrovit A
IDI1_000486
Lard Factor
LMPR01090001
LPK
LS-1578
M.V.C. 9+3
M.V.I.-12
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
Nio-A-Let
NSC 122759
NSC122759
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
retinol
Retinol
RETINOL
Retinol [INN:BAN]
Retinol solution
Retinol-(cellular-retinol-binding-protein)
Retinol, all-trans- (8CI)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
Sehkraft A
SMP2_000102
SMR000112036
Solu-A
SPECTRUM1501203
Spectrum5_000993
Spectrum5_001997
ST057232
Super A
Testavol
Testavol S
Thalasphere
trans-retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
tROL
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-a
Vi-Alpha
Vi-Dom-A
Vio-A
Vitamin A
Vitamin- A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin- A alcohol
Vitamin A alcohol (VAN)
Vitamin- A alcohol solution
Vitamin A cryst
Vitamin A1
Vitamin- A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
Wachstumsvitamin
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
ZINC03831417
Zinosan N
|
|
20 |
|
Lutein |
Approved, Investigational, Nutraceutical |
Phase 3 |
|
127-40-2 |
6433159
|
Synonyms:
3,3'-Dihydroxy-alpha-carotene
all-trans-(+)-Xanthophyll
all-trans-Lutein
beta,epsilon-Carotene-3,3'-diol
bo-Xan
gamma Lutein
Lutein ester
Lutein F
|
Lutein g
Lutein, gamma
Luteine
trans-Lutein
Vegetable lutein
Vegetable luteol
Xanthophyll
Xantofyl
|
|
21 |
|
Vitamin D |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
1406-16-2 |
|
Synonyms:
|
Vitamin D, unspecified form
|
|
22 |
|
Vitamin E |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
59-02-9 |
14985
|
Synonyms:
(+)-alpha-Tocopherol
(+)-a-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-dihydro-2,5,7,8-Tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'r,8'r)-alpha-Tocopherol
(2R,4'r,8'r)-a-Tocopherol
(2R,4'r,8'r)-α-tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-trimethyltocol
5,7,8-Trimethyltocol
a-D-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
alpha-Tocopherol
Amino-Opti-E
Aquasol E
a-Tocopherol
D-alpha-Tocopherol
|
Daltose
D-a-Tocopherol
delta-alpha-Tocopherol
Denamone
d-α-tocopherol
D-α-tocopherol
E-200 I.U. Softgels
E-Complex-600
E-Ferol
Eprolin
E-Vitamin succinate
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-Tocopherol
RRR-alpha-Tocopheryl
Tocopherol
Vitamin e
Vitamin ea
Vitamin Plus E Softgells
Vitec
α-tocopherol
|
|
23 |
|
Tocotrienol |
Investigational |
Phase 3 |
|
6829-55-6 |
|
24 |
|
retinol |
|
Phase 3 |
|
|
|
25 |
|
Retinol palmitate |
|
Phase 3 |
|
|
|
26 |
|
Calciferol |
|
Phase 3 |
|
|
|
27 |
|
Bone Density Conservation Agents |
|
Phase 3 |
|
|
|
28 |
|
Tocotrienols |
|
Phase 3 |
|
|
|
29 |
|
Tocopherols |
|
Phase 3 |
|
|
|
30 |
|
Antihypertensive Agents |
|
Phase 3 |
|
|
|
31 |
|
Isopropyl unoprostone |
|
Phase 3 |
|
|
|
32 |
|
Dexamethasone |
Approved, Investigational, Vet_approved |
Phase 2 |
|
50-02-2 |
5743
|
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
137098-19-2
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16a-Methyl-9a-fluoro-1-dehydrocortisol
16α-methyl-9α-fluoro-1-dehydrocortisol
16α-Methyl-9α-fluoro-1-dehydrocortisol
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-dehydro-16alpha -Methyl-9alpha -fluorohydrocortisone
1-dehydro-16alpha-Methyl-9alpha-fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-dehydro-16a-Methyl-9a-fluorohydrocortisone
1-dehydro-16α-methyl-9α-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9a-fluoro-16a-Methylprednisolone
9a-fluoro-16BETA-METHYLPREDNISOLONE
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -fluoro-16alpha -Methylprednisolone
9alpha-fluoro-16alpha-Methylprednisolone
9alpha-fluoro-16alpha-Methyl-prednisolone
9-alpha-fluoro-16-alpha-Methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9-fluoro-11,17,21-Trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-fluoro-11alpha -Methylpregna-1,4-diene-3,20-dione
9-fluoro-16-Methylprednisolone
9α-fluoro-16α-methylprednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
Adexone
Aeroseb-D
Aeroseb-dex
Aeroseb-Dex
AI3-50934
Ak dex OPH otic soln 0.1%
Alcon brand OF dexamethasone
Alcon Brand of Dexamethasone
alpha -fluoro-16-alpha -Methylcortisol
Anaflogistico
Aphtasolon
Aphthasolone
apo-Dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (veterinary)
Azium (Veterinary)
BIDD:ER0494
BIDD:PXR0060
Bisu Ds
Bisu DS
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
C15643
C22H29FO5
Calonat
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
Corson
Corsone
Cortisumman
CPD001227192
CPD-10549
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-La
Decadron-LA
Decagel
Decaject
Decaject l.a.
Decaject L.A.
Decaject-l.a.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
Delta1-9alpha-fluoro-16alpha-Methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [Dcit]
Desametasone [DCIT]
Desamethasone
Desameton
Deseronil
DEX
Dexa
DEXA
Dexa mamallet
Dexa Mamallet
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexa-cortidelt
Dexa-Cortidelt
Dexacortin
Dexa-cortisyl
Dexa-Cortisyl
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexa-Mamallet
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
dexamethasone
Dexamethasone
Dexaméthasone
Dexamethasone (JP15/USP/INN)
|
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone Acetate
Dexamethasone alcohol
Dexamethasone Alcohol
Dexamethasone base
Dexamethasone Base
Dexamethasone intensol
Dexamethasone Intensol
Dexamethasone sodium phosphate
Dexamethasone Sodium Phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexa-scheroson
Dexa-Scheroson
Dexa-sine
Dexa-Sine
Dexason
Dexasone
Dexasone 0.5MG
Dexasone 0.75MG
Dexasone 4MG
Dexasporin
Dex-ide
Dex-Ide
Dexinolon
Dexinoral
Dexone
Dexone 0.5
DEXONE 0.5
Dexone 0.75
DEXONE 0.75
Dexone 1.5
DEXONE 1.5
Dexone 4
DEXONE 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
DXM
Dxms
DXMS
ECR brand OF dexamethasone
ECR Brand of Dexamethasone
EINECS 200-003-9
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy brand OF dexamethasone
Foy Brand of Dexamethasone
FT-0080377
Gammacorten
Hexadecadrol
Hexadrol
Hexadrol elixir
Hexadrol Elixir
Hexadrol Tablets
Hl-dex
Hl-Dex
HL-Dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
I06-1196
ICN brand OF dexamethasone
ICN Brand of Dexamethasone
IontoDex
isopto-Dex
Isopto-Dex
Lokalison F
Loverine
LS-7300
Luxazone
Maxidex
Maxidex ont 0.1%
Maxidex sus 0.1%
Maxitrol
Mediamethasone
Merck brand OF dexamethasone
Merck Brand of Dexamethasone
Merz brand 1 OF dexamethasone
Merz Brand 1 of Dexamethasone
Merz brand 2 OF dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MK 125
MLS001055412
MLS001332507
MLS001332508
MolMap_000018
MolPort-003-846-433
Mymethasone
Naquasone (veterinary)
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
nchembio809-comp2
NCI60_003067
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
NSC 34521
NSC34521
Ocu-trol
Ocu-Trol
Oradexon
OTO-104
Pet derm III
Pet Derm Iii
Pet Derm III
Pet-Derm Iii
PHL-Dexamethasone
PMS Dexamethasone elixir 0.5mg/5ML
PMS-Dexamethasone
Policort
Posurdex
Prednisolon F
Prednisolone F
Prodex
S1322_Selleck
SAM002548948
Sandoz dexamethasone
SGCUT00126
Sk-Dexamethasone
SK-Dexamethasone
SMP1_000092
SMR000857119
SMR001227192
Spectrum5_002019
Spoloven
ST50307091
Sunia sol D
Sunia Sol D
Superprednol
TL8003317
to_000038
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
|
|
33 |
|
Dexamethasone acetate |
Approved, Investigational, Vet_approved |
Phase 2 |
|
1177-87-3 |
|
Synonyms:
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
9alpha-Fluoro-16alpha-methylprednisolone acetate
Dexamethasone 21-acetate
|
Dexamethasone acetate anhydrous
Dexamethasone acetate, anhydrous
Dexamethasoni acetas
|
|
34 |
|
Valproic acid |
Approved, Investigational |
Phase 2 |
|
99-66-1 |
3121
|
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 PP (base)
2 Propylpentanoic acid
2-N-Propyl-N-valerate
2-n-propyl-n-valeric acid
2-n-Propyl-n-valeric acid
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-propyl-pentanoic acid
2-Propylpentanoic acid
2-Propylpentanoic Acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-propylvaleric acid
2-Propylvaleric acid
2-Propylvaleric Acid
4-Heptanecarboxylate
4-heptanecarboxylic acid
4-Heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
Abbott 44090
AC1L1F7T
AC1Q2ULA
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acide valproique [INN-French]
acido Valproico
Acido valproico
ácido valproico
Acido valproico [INN-Spanish]
acidum valproicum
Acidum valproicum
Acidum valproicum [INN-Latin]
AI3-10500
Alti-valproic
Alti-Valproic
apo-Divalproex
apo-Valproic
apo-Valproic syrup
Avugane
Baceca
BIDD:GT0858
BRN 1750447
C07185
Calcium valproate
Calcium, valproate
CHEBI:39867
CHEMBL109
CID3121
Convulex
Convulsofin
CPD000499581
D00399
DB00313
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetate
di-n-propylacetic acid
Di-n-propylacetic acid
Di-N-propylacetic acid
Di-n-propylessigsaeure
Di-N-propylessigsaeure
Di-n-propylessigsaure
Di-N-propylessigsaure
Di-n-propylessigsäure
Di-n-propylessigsaure [German]
Dipropyl acetate
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DivK1c_000273
DOM-divalproex
Dom-valproate
Dom-Valproic
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
EINECS 202-777-3
Epiject i.v.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
|
KBio2_004845
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
Magnesium valproate
Med valproic
Med Valproic
MLS001076682
MLS001335927
MLS001335928
MLS002415770
MolPort-001-791-895
Mylproin
Myproate
Myproic acid
Myproic Acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
nchembio.79-comp4
nchembio815-comp21
n-Dipropylacetic acid
N-Dipropylacetic acid
n-DPA
N-DPA
NINDS_000273
novo-Divalproex
novo-Valproic
Novo-Valproic
novo-Valproic - ecc
novo-Valproic soft gel cap
NSC 93819
NSC93819
Nu-valproic
Nu-Valproic
P0823
P6273_SIGMA
PEAC
Penta-valproic
Penta-Valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic Acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
ratio-Valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
Sandoz valproic
Savicol
SBB065764
Semisodium valproate
Semisodium Valproate
SMR000499581
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
SPBio_000912
Spectrum_000521
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Sprinkle
Stavzor
UNII-614OI1Z5WI
Valcote
Valparin
valproate
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
valproic acid
Valproic acid
VALPROIC ACID
Valproic acid (USP)
Valproic acid [USAN:INN:BAN]
Valproic acid usp
Valproic acid USP
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproic Acid, Sodium Salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
WLN: QVY3 & 3
|
|
35 |
|
Ciprofloxacin |
Approved, Investigational |
Phase 2 |
|
85721-33-1 |
2764
|
Synonyms:
17850_FLUKA
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O
1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylate
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylIC ACID
1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylate
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylate
1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
33434_FLUKA
33434_RIEDEL
3-Quinolinecarboxylic acid,1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)
85721-33-1
AC1L1EEW
AC-7613
AKOS000269653
Alcon Cilox
Anhydrous, ciprofloxacin hydrochloride
ARONIS020379
Bacquinor
Baflox
BAS 06989041
Bay o 9867
Bay o 9867 (*Hydrochloride*)
BAY q 3939
Bay-09867
Baycip
BAYQ3939
BAY-Q-3939
Bernoflox
Bi-Cipro
BIDD:GT0205
Bio-0540
BPBio1_000140
BRD-K04804440-311-02-3
BRN 3568352
BSPBio_000126
BSPBio_003344
C05349
C17H18FN3O3
CAS-93107-08-5
CBMicro_048498
CCRIS 5241
CHEBI:100241
CHEMBL8
CID2764
Ciflox
Cifloxin
Cilab
Ciloxan
Ciloxan (*Hydrochloride*)
Ciplus
Ciprecu
Ciprinol
Cipro
Cipro (*Hydrochloride*)
Cipro (TN)
Cipro I.V.
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Cipro IV
Cipro XL
Cipro XR
Ciprobay
Ciprobay Uro
Ciprocinol
Ciprodar
Ciproflox
ciprofloxacin
Ciprofloxacin
Ciprofloxacin (JAN/USP/INN)
Ciprofloxacin [USAN:INN:BAN]
Ciprofloxacin dihydrochloride
Ciprofloxacin HCl
Ciprofloxacin Hydrchloride
Ciprofloxacin hydrochloride
Ciprofloxacin hydrochloride anhydrous
Ciprofloxacin monohydrochloride
Ciprofloxacin monohydrochloride monohydrate
Ciprofloxacina
Ciprofloxacine
Ciprofloxacine [INN-French]
Ciprofloxacino
|
Ciprofloxacino [INN-Spanish]
Ciprofloxacinum
Ciprofloxacinum [INN-Latin]
Ciprogis
Ciprolin
Ciprolon
Cipromycin
Ciproquinol
Ciprowin
Ciproxan
Ciproxin
Ciproxina
Ciproxine
Ciriax
Citopcin
Cixan
Corsacin
CPF
CPFX
CRL-1605 & Ciprofloxacin
Cycin
Cyprobay
D00186
DB00537
DivK1c_000095
Eni
Fimoflox
Flociprin
Floxin
HMS1922E18
HMS2090O07
HMS2093I03
HMS500E17
HSDB 6987
Hydrochloride anhydrous, ciprofloxacin
Hydrochloride, ciprofloxacin
IDI1_000095
Ipiflox
Italnik
KBio1_000095
KBio2_000642
KBio2_003210
KBio2_005778
KBio3_002846
KBioGR_001567
KBioSS_000642
Liposomal-ciprofloxacin
Loxan
LS-141563
MLS001336035
MolPort-000-819-654
Monohydrate, ciprofloxacin monohydrochloride
Monohydrochloride monohydrate, ciprofloxacin
NCGC00016959-01
NCGC00095058-01
NCGC00095058-02
NCGC00178128-01
nchembio820-comp1
NINDS_000095
NSC620634
Ocuflox
Oprea1_008239
Oprea1_313572
Prestwick0_000113
Prestwick1_000113
Prestwick2_000113
Prestwick3_000113
Probiox
Proflaxin
Proflox
Proksi 250
Proksi 500
Proquin XR
Quinolid
Quintor
Rancif
Roxytal
Septicide
SMP1_000125
SMR000471901
Sophixin Ofteno
SPBio_001474
SPBio_002065
Spectrum_000162
SPECTRUM1503614
Spectrum2_001567
Spectrum3_001872
Spectrum4_000874
Spectrum5_001089
Spitacin
STK021082
Superocin
Unex
UNII-5E8K9I0O4U
Velomonit
Zumaflox
|
|
36 |
|
Povidone |
Approved |
Phase 2 |
|
9003-39-8 |
|
Synonyms:
1-Ethenyl-2-pyrrolidinone
1-Ethenyl-2-pyrrolidinone (9ci)
1-ethenyl-2-pyrrolidinone homopolymer
1-Ethenyl-2-pyrrolidinone homopolymer
1-Ethenyl-2-pyrrolidinone homopolymer, 9ci
1-Ethenyl-2-pyrrolidinone polymers
1-Ethenyl-2-pyrrolidinone, homopolymer
1-Vinyl-2-pyrrolidinone
1-Vinyl-2-pyrrolidinone cross-linked insoluble polymer
1-Vinyl-2-pyrrolidinone homopolymer
1-vinyl-2-pyrrolidinone polymer
1-Vinyl-2-pyrrolidinone polymer
1-Vinyl-2-pyrrolidinone, monomer
1-Vinyl-2-pyrrolidinone, polymer
1-Vinyl-2-pyrrolidone
1-Vinyl-2-pyrrolidone polymer
1-Vinylpyrrolidin-2-one
1-Vinylpyrrolidinone
1-Vinylpyrrolidone
2-Pyrrolidinone, 1-ethenyl, homopolymer
2-Pyrrolidinone, 1-ethenyl-, homopolymer
2-Pyrrolidinone, 1-vinyl-, polymers
Agent at 717
Agent at-717
Agrimer
Albigen a
Aldacol Q
Antaron P 804
Bolinan
Crospovidone
Disadine
Ganex P 804
Ganex P-804
Hemodesis
Hemodez
K 115 (Polyamide)
K 25
K 25 (Polymer)
K 30
K 30 (Polymer)
K 60
K 60 (Polymer)
K115 (Polyamide)
K25 (Polymer)
K30 (Polymer)
K60 (Polymer)
Kollidin CLM
Kollidon
Kollidon 17
Kollidon 25
'Kollidon 25'
Kollidon 30
Kollidon CL
Luviskol
Luviskol K 30
Luviskol K 90
Luviskol K30
Luviskol K-30
Luviskol K90
Neocompensan
N-Vinyl pyrrolidone
N-Vinyl-2-pyrrolidinone
N-Vinyl-2-pyrrolidone
N-Vinyl-2-pyrrolidone polymer
N-Vinylbutyrolactam polymer
N-Vinylpyrrolidinone
N-Vinylpyrrolidinone polymer
N-Vinylpyrrolidone
N-Vinylpyrrolidone polymer
N-Vinylpyrrolidone-2
Peragal ST
Peregal ST
Periston
Periston-N
Peviston
'plasdone'
Plasdone
Plasdone 4
Plasdone K 29-32
Plasdone K-26/28
Plasdone no. 4
|
Plasdone XL
Plasmosan
Polividone
Poly(1-(2-oxo-1-pyrrolidinyl)-1,2-ethanediyl)
Poly(1-(2-oxo-1-pyrrolidinyl)ethylene)
Poly(1-ethenyl-2-pyrrolidinone)
Poly(1-vinyl-2-pyrrolidinone)
Poly(1-vinyl-2-pyrrolidinone) homopolymer
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.1
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.2
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.3
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.4
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.5
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.6
Poly(1-vinyl-2-pyrrolidinone) hueper's polymer no.7
Poly(1-vinyl-2-pyrrolidone)
Poly(1-vinylpyrrolidinone)
Poly(N-vinyl-2-pyrrolidinone)
Poly(N-vinyl-2-pyrrolidone)
Poly(N-vinylbutyrolactam)
Poly(N-vinylpyrrolidinone)
Poly(N-vinylpyrrolidone)
Poly(vinylpolypyrrolidone)
Poly(vinylpyrrolidinone)
Poly(vinylpyrrolidone)
Polyclar a. t
Polyclar a. t.
Polyclar at
Polyclar H
Polyclar L
Polyclar-at
Polygyl
Poly-N-vinyl pyrrolidone
Poly-N-vinylpyrrolidone
Polyplasdone
Polyplasdone XL
Polyvidonum
Polyvinyl pyrrolidone
Polyvinylpolypyrrolidone
Polyvinylpyrrolidone
Polyvinylpyrrolidone polymers
Polyvinylpyrrolidone, cross-linked
Povidona
Povidone
Povidone(usan)
Povidone, ban, usan
Povidone, unspecified
Povidonum
Protagent
PVP 1
PVP 2
PVP 3
PVP 4
PVP 5
PVP 6
PVP 7
PVP K 3
PVP10_SIAL
PVP40_SIAL
PVP-K 15
PVP-K 3
PVP-K 30
PVP-K 60
PVP-K 90
PVPP
Refresh
Sauflon
Soothe
Subtosan
Tears plus
Tolpovidone I 131
Tolpovidone I-131
Toxobin
Vinisil
Vinyl-2-pyrrolidone
Vinylbutyrolactam
Vinylpyrrolidinone
Vinylpyrrolidinone polymer
Vinylpyrrolidone
Vinylpyrrolidone polymer
V-Pyrol
|
|
37 |
|
Iodine |
Approved, Investigational |
Phase 2 |
|
7553-56-2 |
807
|
Synonyms:
diiodine
I2
Iode
Iodine-molecule
Iodio
iodo
|
Iodum
Jod
Jood
molecular iodine
Molecular iodine
Tincture iodine
|
|
38 |
|
Povidone-iodine |
Approved |
Phase 2 |
|
25655-41-8 |
|
Synonyms:
Iodopovidone
Povidone iodine
|
|
|
39 |
|
Minocycline |
Approved, Investigational |
Phase 1, Phase 2 |
|
10118-90-8 |
5281021
|
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-dimethylamino-6-Demethyl-6-deoxytetracycline
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Alti-Minocycline
Apo-Minocycline
Arestin
Bio-0062
Borymycin
BRN 3077644
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
Gen-Minocycline
HMS2090D03
HSDB 3130
Klinomycin
Lactoferrin B & Minocycline
|
Lactoferrin H & Minocycline
LMPK07000002
LS-93850
MINO
Minociclina
Minociclina [INN-Spanish]
minociclinum
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
minocycline
Minocycline
Minocycline (USAN/INN)
Minocycline [USAN:BAN:INN]
Minocycline HCl
Minocycline Monohydrochloride
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minomycin
MIY
NCGC00178854-01
nchembio.559-comp1
Novo-Minocycline
NSC 141993
NSC141993
Solodyn
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
|
|
40 |
|
Dopamine |
Approved |
Phase 2 |
|
51-61-6, 62-31-7 |
681
|
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
41 |
|
Levodopa |
Approved |
Phase 2 |
|
59-92-7 |
6047
|
Synonyms:
(-)-(3,4-Dihydroxyphenyl)alanine
(−)-3-(3,4-dihydroxyphenyl)-L-alanine
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(−)-dopa
(-)-Dopa
(2S)-2-amino-3-(3,4-Dihydroxyphenyl)propanoate
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
(2S)-2-amino-3-(3,4-Dihydroxyphenyl)propanoic acid
.Beta.-(3, 4-Dihydroxyphenyl)alanine
.Beta.-(3,4-Dihydroxyphenyl)-L-alanine
1E83F927-C221-46AA-B90A-81B33C5F3868
23734-74-9
25525-15-9
2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
3 Hydroxy L tyrosine
3-(3,4-Dihydroxypheny
3-(3,4-Dihydroxyphenyl)-L-alanine
3, 4-Dihydroxy-L-phenylalanine
3, 4-Dihydroxyphenylalanine
3,4-dihydroxy-L-phenylalanine
3,4-Dihydroxy-L-phenylalanine
3,4-dihydroxyphenylalanine
3,4-Dihydroxyphenylalanine
3,4-DIHYDROXYPHENYLALANINE
3,4-Dihydroxyphenylalanine (VAN)
3,4-Dihydroxyphenyl-L-alanine
34241-25-3
37830_FLUKA
3-Hydroxy-L-tyrosine
587-45-1
59-92-7
72572-99-7
72573-00-3
88250-23-1
90638-38-3
AC-11686
AC1L1LOR
AC1Q4U7F
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
b-(3,4-Dihydroxyphenyl)-L-alanine
Bendopa
beta-(3,4-Dihydroxyphenyl)alanine
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
BIDD:GT0158
Bio-0575
Biodopa
bmse000322
BPBio1_000059
Brocadopa
BSPBio_000053
BSPBio_002354
C00355
C9H11NO4
CAS-59-92-7
CCRIS 3766
Cerepap
CHEBI:15765
CHEMBL1009
CID6047
Cidandopa
component of Sinemet
D 9628
D00059
D0600
D9628
D9628_SIGMA
DAH
DB01235
Deadopa
Dihydroxy-L-phenylalanine
Dihydroxyphenylalanine
DivK1c_000452
Dopa
DOPA
Dopaflex
Dopaidan
Dopal
Dopal-fher
Dopal-Fher
Dopalina
Dopar
Dopar (TN)
Doparkine
Doparl
Dopasol
Dopaston
Dopaston SE
Dopastone
Dopastral
Dopicar
Doprin
EINECS 200-445-2
Eldopal
Eldopar
Eldopatec
EU-0100454
Eurodopa
Helfo DOPA
|
helfo-Dopa
Helfo-Dopa
HMS1568C15
HMS1922J14
HMS2090O08
HMS2093N04
HMS501G14
HSDB 3348
IDI1_000452
InChI=1/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14
Insulamina
IV Levodopa
KBio1_000452
KBio2_000934
KBio2_003502
KBio2_006070
KBioGR_001177
KBioSS_000934
L 3,4 Dihydroxyphenylalanine
L Dopa
L(-)-Dopa
L-(-)-Dopa
L-(3, 4-Dihydroxyphenyl)-.alpha.-alani
L-(3, 4-Dihydroxyphenyl)alanine
L-(o-Dihydroxyphenyl)alanine
l)-L-alanine
L-.Beta.-(3,4-Dihydroxyphenyl)alanine
L-3-(3,4-Dihydroxyphenyl)alanine
L-3-(3,4-Dihydroxyphenyl)-alanine
L-3,4-dihydroxyphenylalanine
L-3,4-Dihydroxyphenylalanine
L-3-Hydroxytyrosine
L-4-5-Dihydroxyphenylalanine
Laradopa
Larodopa
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-b-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-Dihydroxyphenylalanine
L-DOPA
L-DOPA, Parcopa, Atamet, Stalevo, Madopar, Prolopa, Dopar, 3,4-Dihydroxyphenylalanine, Levodopa
Ledopa
Levedopa
Levodopa
Levodopa (JP15/USP)
Levodopa (JP15/USP/INN)
Levodopa [USAN:INN:BAN:JAN]
Levodopum
Levodopum [INN-Latin]
Levopa
L-O-Dihydroxyphenylalanine
L-o-Hydroxytyrosine
Lopac0_000454
Lopac-D-9628
LS-255
L-β-(3,4-dihydroxyphenyl)alanine
Maipedopa
medphano Brand OF levodopa
MLS000028514
MolPort-000-856-937
NCGC00015384-01
NCGC00016270-01
NCGC00016270-06
NCGC00093869-04
nchembio.2007.55-comp26
nchembio.89-comp9
ne
NINDS_000452
NSC 118381
NSC118381
Parda
Pardopa
PDSP1_001541
PDSP2_001525
Prestwick_185
Prestwick0_000017
Prestwick1_000017
Prestwick2_000017
Prestwick3_000017
Prodopa
Ro 4-6316
Roberts brand OF levodopa
Roche brand OF levodopa
S1726_Selleck
SDCCGMLS-0066924.P001
SMR000058312
Sobiodopa
SPBio_000391
SPBio_001974
Spectrum_000454
Spectrum2_000496
SPECTRUM2300205
Spectrum4_000539
Spectrum5_001899
Syndopa
UNII-46627O600J
Veldopa
Weldopa
β-(3,4-dihydroxyphenyl)alanine
β-(3,4-dihydroxyphenyl)-L-alanine
|
|
42 |
|
Carbidopa |
Approved |
Phase 2 |
|
28860-95-9 |
34359
|
Synonyms:
(-)-L-a-hydrazino-3,4-Dihydroxy-a-methylhydrocinnamate
(-)-L-a-hydrazino-3,4-Dihydroxy-a-methylhydrocinnamic acid
(-)-L-alpha-hydrazino-3,4-Dihydroxy-alpha-methylhydrocinnamate
(-)-L-alpha-hydrazino-3,4-Dihydroxy-alpha-methylhydrocinnamic acid
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid
(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate
(-)-L-α-hydrazino-3,4-dihydroxy-α-methylhydrocinnamate
(-)-L-α-hydrazino-3,4-dihydroxy-α-methylhydrocinnamic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid monohydrate
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid--water (1/1)
(AlphaS)-a-hydrazino-3,4-dihydroxy-a-methylbenzenepropanoate
(AlphaS)-a-hydrazino-3,4-dihydroxy-a-methylbenzenepropanoic acid
(AlphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoate
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
(AlphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid
(alphaS)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate
(AlphaS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoate
(AlphaS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
(S)-(-)-carbidopa
(S)-(−)-carbidopa
(S)-(-)-Carbidopa
(S)-(-)-carbidopa hydrate
(S)-alpha--Hydrazino-3,4-dihydroxy-alpha--methyl-benzenepropanoic acid monohydrate
(S)-carbidopa
(S)-Carbidopa
(S)-carbidopa hydrate
(αS)-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid
27925-91-3
28860-95-9
31823-41-3
38821-49-7
AC-1676
AC1L1RFR
AC1L1Z32
AC1Q5QGW
alpha-Hydrazino-alpha-methyl-beta-(3,4-dihydroxyphenyl)propionic acid
alpha-Methyldopahydrazine
Atamet
BB_SC-5095
Benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)
C-126
C126_SIGMA
C1335_SIGMA
carbidopa
Carbidopa
Carbidopa (anhydrous)
Carbidopa [USAN:INN:BAN]
Carbidopa anhydrous
Carbidopa hydrate
Carbidopa Monohydrate
Carbidopa, (R)-isomer
Carbidopa, (S)-isomer
Carbidopa, (S)-Isomer
Carbidopa, Entacapone, & Levodopa
Carbidopa-1-wasser
|
Carbidopum
Carbidopum [INN-Latin]
carbidopum monohydricum
CCRIS 5093
C-DOPA
CHEBI:3395
CHEBI:39585
CHEMBL1200748
CHEMBL1201236
CID34359
CID38101
CPD-11550
DB00190
EINECS 249-271-9
EU-0100382
Hadrazino-alpha-methyldopa
HMS2089B12
Hydrocinnamic acid, (-)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate
KINSON, 3-(3,4-DIHYDROXY-PHENYL)-2-HYDRAZINO-2-METHYL-PROPIONIC ACID
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionate
L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid
L-alpha-(3,4-dihydroxybenzyl)-alpha-hydrazinopropionic acid monohydrate
L-alpha-Methyl-alpha-hydrazino-beta-(3,4-dihydroxyphenylpropionic acid
L-alpha-Methyl-beta-(3,4-dihydroxyphenyl)-alpha-hydrazinopropionic acid
L-alpha-Methyldopahydrazine
L-a-Methyldopahydrazine
Lodosin
Lodosyn
Lodosyn, Carbidopa
Lopac0_000382
LS-77199
L-α-methyldopahydrazine
Methyldopahydrazine
MK 486
MK-485
MK-486
MLS000069628
MLS002207014
MolPort-003-940-629
MolPort-005-934-181
N-Aminomethyldopa
NCGC00024596-01
NCGC00024596-03
NCGC00024596-05
NCGC00024596-06
S-(-)-alpha-Hydrazino-3,4-dihydroxy-2-methylbenzenepropanoic acid
S(-)-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate
S-(-)-Carbidopa
S(-)-CARBIDOPA
S1891_Selleck
SMP1_000057
SMR000058235
ST055523
Stalevo
Tocris-0455
UNII-KR87B45RGH
UNII-MNX7R8C5VO
|
|
43 |
|
Adapalene |
Approved |
Phase 1, Phase 2 |
|
106685-40-9 |
60164
|
Synonyms:
106685-40-9
271, CD
6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoate
6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid
6-(3-adamantan-1-yl-4-methoxyphenyl)naphthalene-2-carboxylic acid
6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid
6-[3-(adamantan-1-yl)-4-methoxyphenyl]-2-naphthoic acid
AC-1974
AC1L1SOH
AC1Q5USH
Adaferin
Adapalene
ADAPALENE
Adapalène
Adapalene (JAN/USAN/INN)
Adapalene [USAN:BAN:INN]
Adapaleno
Adapaleno [INN-Spanish]
Adapalenum
Adapalenum [INN-Latin]
AKOS005145841
Ambap106685-40-9
BIDD:GT0264
C28H28O3
CD 271
CD271
|
CD-271
CHEBI:217732
CHEBI:31174
CHEMBL1265
CHEMBL76401
CID60164
CPD000466349
D01112
DB00210
Differin
Differin (TN)
Differin, Adapalene
Differine
I06-0642
KS-1196
LS-172017
MLS000759463
MolPort-003-986-211
MolPort-006-823-940
NCGC00164617-01
S1276_Selleck
SAM001246663
SMR000466349
TL8000241
UNII-1L4806J2QF
|
|
44 |
|
Ranibizumab |
Approved |
Phase 2 |
|
347396-82-1 |
459903
|
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
ranibizumab
|
Ranibizumab
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
Ranibizumab (USAN/INN)
rhuFab V2
|
|
45 |
|
Acetazolamide |
Approved, Vet_approved |
Phase 2 |
|
59-66-5 |
1986
|
Synonyms:
1424-27-7 (mono-hydrochloride salt)
1yda
1ydb
1ydd
1zsb
2-acetylamino-1,3,4-thiadiazole-5-sulfonamide
2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide
2-acetylamino-1,3,4-Thiadiazole-5-sulphonamide
2h4n
3czv
4-Diamox
5661-25-6
59-66-5
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
5-acetamido-1,3,4-THIADIAZOLE-2-sulfonamide
5-acetamido-1,3,4-THIADIAZOLE-2-sulphonamide
5-acetylamino-1,3,4-thiadiazole-2-sulfonamide
5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide
5-acetylamino-1,3,4-Thiadiazole-2-sulphonamide
8017-69-4
A 6011
A6011_SIAL
A6011_SIGMA
AB00051906
AC-12779
AC1L1CO5
Acetadiazol
Acetamidothiadiazolesulfonamide
Acetamox
Acetazolam
Acetazolamid
Acetazolamida
Acetazolamida [INN-Spanish]
acetazolamide
Acetazolamide
Acétazolamide
Acetazolamide (AAZ)
Acetazolamide (JP15/USP/INN)
Acetazolamide [INN:BAN:JAN]
Acetazolamide apotex brand
Acetazolamide Apotex Brand
Acetazolamide chiesi brand
Acetazolamide Chiesi Brand
Acetazolamide dioptic brand
Acetazolamide Dioptic Brand
Acetazolamide grin brand
Acetazolamide Grin Brand
Acetazolamide icn brand
Acetazolamide ICN Brand
Acetazolamide jumer brand
Acetazolamide Jumer Brand
Acetazolamide llorens brand
Acetazolamide Llorens Brand
Acetazolamide medphano brand
Acetazolamide Medphano Brand
Acetazolamide novopharm brand
Acetazolamide Novopharm Brand
Acetazolamide orion brand
Acetazolamide Orion Brand
Acetazolamide Sodium
Acetazolamide sodium, (sterile)
Acetazolamide Sodium, (Sterile)
Acetazolamide wassermann brand
Acetazolamide Wassermann Brand
Acetazolamide, monosodium salt
Acetazolamide, Monosodium Salt
Acetazolamidum
Acetazolamidum [INN-Latin]
Acetazolamine
Acetazoleamide
Acetozalamide
AI3-52458
Ak zol
Ak Zol
AKOS000715163
Ak-zol
AkZol
Ak-Zol
apo Acetazolamide
Apo Acetazolamide
apo-Acetazolamide
ApoAcetazolamide
Apo-Acetazolamide
Apotex brand OF acetazolamide
Apotex Brand of Acetazolamide
Atenezol
BAS 01585728
BIDD:GT0643
BPBio1_000007
BSPBio_000005
BSPBio_001788
C06805
C4H6N4O3S2
Carbonic anhydrase inhibitor 6063
Carbonic Anhydrase Inhibitor 6063
Carbonic Anhydrase Inhibitor No. 6063
CAS-59-66-5
CCRIS 5811
CHEBI:27690
CHEMBL20
Chiesi brand OF acetazolamide
Chiesi Brand of Acetazolamide
Ciba vision brand OF acetazolamide
Ciba Vision Brand of Acetazolamide
CID1986
Cidamex
CPD000058394
CPD0-1626
Cyanamid brand OF acetazolamide preparation
D000086
D00218
Dazamide
DB00819
Defiltran
Défiltran
Dehydratin
Diacarb
Diakarb
Diamox
|
Diamox (TN)
Diamox Sequels
Didoc
Diluran
Dioptic brand OF acetazolamide
Dioptic Brand of Acetazolamide
Diuramid
Diuramide
Diureticum-holzinger
Diureticum-Holzinger
Diuriwas
Diutazol
DivK1c_000017
Donmox
Duiramid
Edemox
EINECS 200-440-5
EU-0100039
Eumicton
Fonurit
Glauconox
Glaumox
Glaupax
Glupax
Grin brand OF acetazolamide
Grin Brand of Acetazolamide
HMS1568A07
HMS1920A05
HMS2091G05
HMS500A19
HSDB 3002
Huma zolamide
Huma Zolamide
Huma-zolamide
HumaZolamide
Huma-Zolamide
I09-0425
ICN brand OF acetazolamide
ICN Brand of Acetazolamide
IDI1_000017
Jumer brand OF acetazolamide
Jumer Brand of Acetazolamide
KBio1_000017
KBio2_000358
KBio2_002926
KBio2_005494
KBio3_001288
KBioGR_000558
KBioSS_000358
Lederle brand OF acetazolamide preparation
Llorens brand OF acetazolamide
Llorens Brand of Acetazolamide
Lopac0_000039
Lopac-A-6011
LS-10227
medphano Brand OF acetazolamide
Medphano Brand of Acetazolamide
MLS000028435
MLS001148438
MolPort-001-783-578
Monosodium salt acetazolamide
Monosodium Salt Acetazolamide
N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
N-[5-(Aminosulphonyl)-1,3,4-thiadiazol-2-yl]acetamide
N-[5-(Aminosulphonyl)-1,3,5-thiadiazol-2-yl]acetamide
Natrionex
NCGC00015074-01
NCGC00015074-02
NCGC00015074-03
NCGC00015074-06
NCGC00015074-11
NCGC00023455-03
NCGC00023455-04
NCGC00023455-05
NCGC00023455-06
NCGC00023455-07
Nephramid
Nephramide
NINDS_000017
Novopharm brand OF acetazolamide
Novopharm Brand of Acetazolamide
NSC 145177
NSC145177
Orion brand OF acetazolamide
Orion Brand of Acetazolamide
Phonurit
Prestwick_4
Prestwick0_000003
Prestwick1_000003
Prestwick2_000003
Prestwick3_000003
SAM002554883
SBB056640
Sk-Acetazolamide
SK-acetazolamide
SMR000058394
SPBio_000004
SPBio_001926
Spectrum_000018
SPECTRUM1500102
Spectrum2_000082
Spectrum3_000284
Spectrum4_000139
Spectrum5_000738
Storz brand OF acetazolamide preparation
Storz Brand of Acetazolamide Preparation
Storzolamide
Théraplix brand OF acetazolamide preparation
UNII-O3FX965V0I
Vetamox
Wassermann brand OF acetazolamide
Wassermann Brand of Acetazolamide
Whelehan brand OF acetazolamide preparation
WLN: T5NN DSJ CSZW EMV1
Wyeth brand OF acetazolamide preparation
Wyeth Brand of Acetazolamide Preparation
|
|
46 |
|
Brinzolamide |
Approved |
Phase 2 |
|
138890-62-7 |
68844
|
Synonyms:
(+)-4-ETHYLAMINO-3,4-DIHYDRO-2-(METHOXY)PROPYL-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide
(R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide
(R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide 1,1-dioxide
138890-62-7
2H-Thieno(3,2-e)-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide,R
3znc
AB00513824
AC1L2AKA
AC1Q6UVB
AC-5277
AKOS005145708
AL 4862
AL04862
AL-4862
Alcon brand of brinzolamide
Alcon brand OF brinzolamide
Allphar brand of brinzolamide
Allphar brand OF brinzolamide
Azopt
Azopt (TN)
BIDD:GT0039
Birnzolamide
BPBio1_000539
BRD-K74913225-001-03-3
Brinzolamida
|
Brinzolamide
Brinzolamide (BRZ)
Brinzolamide (JAN/USP/INN)
Brinzolamide [USAN]
BSPBio_000489
BZ1
C07760
C111827
C12H21N3O5S3
CHEBI:3176
CHEMBL220491
CID68844
D00652
DB01194
FT-0082471
HMS1569I11
I09-0605
LS-173036
MLS002153787
MolPort-005-940-291
Prestwick0_000365
Prestwick1_000365
Prestwick2_000365
Prestwick3_000365
SMR001233169
SPBio_002410
UNII-9451Z89515
|
|
47 |
|
Beta carotene |
Approved, Nutraceutical |
Phase 1, Phase 2 |
|
7235-40-7 |
|
Synonyms:
all-trans-β-carotene
Beta carotene
beta-carotene
|
|
|
48 |
|
Antiemetics |
|
Phase 2 |
|
|
|
49 |
|
HIV Protease Inhibitors |
|
Phase 2 |
|
|
|
50 |
|
glucocorticoids |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 183)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Prospective, Randomized, 3-arm Parallel Trial to Evaluate the Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Treatment |
Unknown status |
NCT00498680
|
Phase 4 |
Sildenafil, Vardenafil;Sildenafil;Vardenafil;Sildenafil & Vardenafil |
2 |
Role of Capsular Tension Ring in Anterior Capsular Contraction in Retinitis Pigmentosa Patients |
Completed |
NCT00717080
|
Phase 4 |
|
3 |
Correlation of Functional and Structural Outcomes With Serum Antibody Profiles in Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial |
Completed |
NCT02843490
|
Phase 4 |
Ranibizumab |
4 |
An Integrated Approach With Vardenafil Orodispersible and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV) |
Completed |
NCT02450188
|
Phase 4 |
Vardenafil |
5 |
Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis |
Terminated |
NCT00854750
|
Phase 4 |
ACTHAR;ACTHAR;ACTHAR;ACTHAR |
6 |
Randomized Clinical Trial for Retinitis Pigmentosa |
Completed |
NCT00346333
|
Phase 3 |
Lutein |
7 |
Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa |
Completed |
NCT00000114
|
Phase 3 |
Vitamin E;Vitamin A |
8 |
Randomized Trial for Retinitis Pigmentosa |
Completed |
NCT00000116
|
Phase 3 |
Vitamin A;Nutritional Supplement |
9 |
A Dose Escalation (Phase 1), and Dose Expansion (Phase 2/3) Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using an Adeno-Associated Viral Vector (AAV8) Encoding Retinitis Pigmentosa GTPase Regulator (RPGR) |
Recruiting |
NCT03116113
|
Phase 2, Phase 3 |
|
10 |
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Patients With Retinitis Pigmentosa |
Recruiting |
NCT01680510
|
Phase 2, Phase 3 |
|
11 |
Management of Low Risk Ductal Carcinoma in Situ (Low-risk DCIS): a Randomized, Multicentre, Non-inferiority Trial, Between Standard Therapy Approach Versus Active Surveillance |
Recruiting |
NCT02492607
|
Phase 3 |
|
12 |
A Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 to the Retinal Pigment Epithelium (RPE) [AAV2-hRPE65v2-301] |
Active, not recruiting |
NCT00999609
|
Phase 3 |
|
13 |
Phase III Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period |
Terminated |
NCT01786395
|
Phase 3 |
UF-021;Placebo |
14 |
Argus® II Retinal Stimulation System Feasibility Protocol |
Unknown status |
NCT00407602
|
Phase 2 |
|
15 |
An Open Labeled Clinical Study to Evaluate the Safety and Efficacy OF Autologous Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Retinitis Pigmentosa. It is Self Funded (Patients' Own Funding) Clinical Trial |
Unknown status |
NCT01914913
|
Phase 1, Phase 2 |
|
16 |
Prospective Non-randomised Exploratory Study to Assess the Safety and Efficacy of Aflibercept (Eylea) in Cystoid Macular Oedema (CMO) Associated With Retinitis Pigmentosa (RP) |
Unknown status |
NCT02661711
|
Phase 2 |
Aflibercept |
17 |
Dexamethasone in Retinitis Pigmentosa Cystoid Macular Edema |
Unknown status |
NCT02804360
|
Phase 2 |
|
18 |
A 24 Week Phase Ib/II, Multicenter, Randomized, Controlled, Parallel Group, Dose Ranging Study With a 24 Week Follow-up to Evaluate Safety and Potential Efficacy of 2 Doses (60, 180 µg/ml) of rhNGF Solution vs Vehicle in Patients With RP. |
Completed |
NCT02110225
|
Phase 1, Phase 2 |
rhNGF 60 µg/ml eye drops solution;rhNGF 180 µg/ml eye drops solution;Placebo |
19 |
Nerve Growth Factor Eye Drops as a Novel Treatment for Vision Loss in Patients With Retinitis Pigmentosa: From Preclinical to Clinical Phase II Trial |
Completed |
NCT02609165
|
Phase 2 |
rhNGF 180 µg/ml eye drops solution;vehicle eye drops |
20 |
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa |
Completed |
NCT01399515
|
Phase 2 |
Valproic Acid |
21 |
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa |
Completed |
NCT00661479
|
Phase 1, Phase 2 |
400 µg Brimonidine Tartrate Implant;200 µg Brimonidine Tartrate Implant;100 µg Brimonidine Tartrate Implant |
22 |
A Phase II Multiple Site, Randomized, Placebo-Controlled Trial of Oral Valproic Acid for Autosomal Dominant Retinitis Pigmentosa |
Completed |
NCT01233609
|
Phase 2 |
Valproic Acid;Placebo |
23 |
A Prospective, Multicenter, Open-Label, Single-Arm Study of the Safety and Tolerability of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP) |
Completed |
NCT02320812
|
Phase 1, Phase 2 |
|
24 |
Safety Study in Retinal Transplantation for Retinitis Pigmentosa. |
Completed |
NCT00345917
|
Phase 2 |
|
25 |
Phase 2 Study Of Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa |
Completed |
NCT01560715
|
Phase 2 |
|
26 |
A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Visual Acuity as the Primary Outcome |
Completed |
NCT00447993
|
Phase 2 |
NT-501;NT-501 |
27 |
A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Visual Field Sensitivity as the Primary Outcome |
Completed |
NCT00447980
|
Phase 2 |
NT-501;NT-501 |
28 |
Investigation of Effectiveness and Safety of High Dose Docosahexaenoic Acid (DHA) in X-Linked Retinitis Pigmentosa |
Completed |
NCT00100230
|
Phase 2 |
docosahexaenoic acid OR corn/soy oil placebo |
29 |
Pilot Study to Evaluate Oral Minocycline in the Treatment of Cystoid Macular Edema Associated With Retinitis Pigmentosa |
Completed |
NCT02140164
|
Phase 1, Phase 2 |
Minocycline |
30 |
An Open Label Dose Escalation Phase 1 Clinical Trial of Retinal Gene Therapy for Choroideraemia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1) |
Completed |
NCT01461213
|
Phase 1, Phase 2 |
rAAV2.REP1 |
31 |
The Effect of L-Dopa on the Progression of Retinitis Pigmentosa |
Recruiting |
NCT02837640
|
Phase 2 |
levodopa-carbidopa |
32 |
Phase I/IIa, Open-Label, Dose-Escalation Study of Safety and Tolerability of Intravitreal RST-001 in Patients With Advanced Retinitis Pigmentosa (RP) |
Recruiting |
NCT02556736
|
Phase 1, Phase 2 |
RST-001 |
33 |
An Open Label, Multi-centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV2-.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR) |
Recruiting |
NCT03252847
|
Phase 1, Phase 2 |
|
34 |
First-in-human Phase I/IIa, Open-Label, Prospective Study of the Safety and Tolerability of Subretinally Transplanted Human Retinal Progenitor Cells (hRPC) in Patients With Retinitis Pigmentosa (RP) |
Recruiting |
NCT02464436
|
Phase 1, Phase 2 |
hRPC |
35 |
A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa |
Recruiting |
NCT03326336
|
Phase 1, Phase 2 |
|
36 |
An Open-label First-in-human Single Ascending Dose Study to Explore Safety, Tolerability and Efficacy of Subretinal Administration of CPK850 Gene Therapy in Patients With Retinitis Pigmentosa Due to Mutations in the Retinaldehyde Binding Protein 1 (RLBP1) Gene |
Recruiting |
NCT03374657
|
Phase 1, Phase 2 |
|
37 |
A Phase I/IIa Dose Escalation Safety Study of Subretinally Injected SAR421869, Administered to Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B |
Recruiting |
NCT01505062
|
Phase 1, Phase 2 |
|
38 |
A First-in-Human Study to Evaluate the Safety and Tolerability of QR-421a in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene |
Recruiting |
NCT03780257
|
Phase 1, Phase 2 |
QR-421a |
39 |
Safety and Efficacy of a Unilateral Subretinal Administration of HORA-PDE6B in Patients With Retinitis Pigmentosa Harbouring Mutations in the PDE6B Gene Leading to a Defect in PDE6ß Expression |
Recruiting |
NCT03328130
|
Phase 1, Phase 2 |
|
40 |
An Open-Label Dose Escalation Study to Evaluate the Safety and Efficacy of AGTC-501 (rAAV2tYF-GRK1-RPGR) in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations |
Recruiting |
NCT03316560
|
Phase 1, Phase 2 |
|
41 |
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) |
Recruiting |
NCT01773278
|
Phase 2 |
Antioxidants;Cholesterol |
42 |
Photoreceptor Structure in A Phase 2 Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants With Retinitis Pigmentosa Using Rates of Change in Cone Spacing and Density |
Active, not recruiting |
NCT01530659
|
Phase 2 |
NT-501 |
43 |
Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa |
Active, not recruiting |
NCT02709876
|
Phase 1, Phase 2 |
|
44 |
A Prospective, Multicenter, Randomized, Study of the Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP) |
Active, not recruiting |
NCT03073733
|
Phase 2 |
|
45 |
Efficacy and Safety of Intravitreal Ranibizumab (Lucentis®) Injection in the Treatment of Non-leaking Macular Cysts in Patients With Retinal Dystrophy. |
Active, not recruiting |
NCT03763227
|
Phase 2 |
Intravitreal ranibizumab (IVR) injection;Carbonic Anhydrase Inhibitor (CAI) therapy |
46 |
STREAM: A Phase 1/2, Open-label, Safety, Tolerability and Preliminary Efficacy Study of Implantation Into One Eye of hESC-derived RPE in Patients With Retinitis Pigmentosa Due to Monogenic Mutation |
Not yet recruiting |
NCT03963154
|
Phase 1, Phase 2 |
|
47 |
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa |
Not yet recruiting |
NCT02018692
|
Phase 1, Phase 2 |
|
48 |
An Open-Label, Phase 1b, Safety/Proof-of-Concept Study to Evaluate the Effects of Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65) |
Completed |
NCT01543906
|
Phase 1 |
QLT091001 |
49 |
Phase 1b Study to Evaluate QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) |
Completed |
NCT01014052
|
Phase 1 |
QLT091001 |
50 |
Phase I Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa |
Completed |
NCT02280135
|
Phase 1 |
|
|